Due to the unusual occurrence of anti-fibrillarin autoantibodies in pediatric patients and the concomitantly EBV infection, a comment in the report was included as follows: ‘The positivity of anti-fibrillarin autoantibodies represents a rare finding in paediatric patients, thus requiring a rheumatological evaluation. This evidence concerns the gene FBL and Epstein-Barr virus infection.